US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BioStem Technologies, Inc.

2.73

-0.3400-11.07%

Post-market: 2.740.0099+0.36%19:30 EDT

Volume:158.10K

Turnover:443.97K

Market Cap:48.96M

PE:-1.63

High:3.07

Open:3.03

Low:2.69

Close:3.07

52wk High:8.40

52wk Low:2.25

Shares:17.94M

Float Shares:14.04M

Volume Ratio:0.85

T/O Rate:1.13%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.6713

EPS(LYR):-0.3934

ROE:-74.74%

ROA:-18.07%

PB:1.77

PE(LYR):-6.94

Loading ...

Overview Company News Filings

BRIEF-Biostem Technologies Announces Appointment Of Three New Members To Its Board Of Directors

Press Release: BioStem Technologies Announces Appointment of Three New Members to its Board of Directors

Biostem Technologies Announces Appointment of Three New Members to Its Board of Directors

THOMSON REUTERS

Biostem Technologies Announces $2.5 Million Private Placement Financing With Its First Institutional Investor

THOMSON REUTERS

BioStem Technologies price target lowered to $7 from $9 at H.C. Wainwright

Press Release: BioStem Technologies Reports First Quarter 2026 Financial Results

BioStem Technologies Q1 revenue falls 62% yr/yr

Biostem Technologies, Inc. Q1 EPS USD -0.52

THOMSON REUTERS

Biostem Technologies initiated with a Buy at H.C. Wainwright

Press Release: BioStem Strengthens Leadership Team with Appointment of Katherine Gorrell as Chief Legal & Compliance Officer

Biostem Strengthens Leadership Team With Appointment of Katherine Gorrell as Chief Legal & Compliance Officer

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/BSEM/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BSEM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BSEM\",,,,,undefined,":{"symbol":"BSEM","market":"US","secType":"STK","nameCN":"BioStem Technologies, Inc.","latestPrice":2.73,"timestamp":1790971200000,"preClose":3.07,"halted":0,"volume":158103,"hourTrading":{"tag":"盘后","latestPrice":2.7399,"preClose":2.73,"latestTime":"19:30 EDT","volume":812,"amount":2210.1048,"timestamp":1790983852108,"change":0.0099,"changeRate":0.003626,"amplitude":0.012491},"delay":0,"changeRate":-0.11074918566775241,"floatShares":14044269,"shares":17935843,"eps":-1.671347,"marketStatus":"Market Closed","change":-0.34,"latestTime":"10-02 16:00:00 EDT","open":3.03,"high":3.0699,"low":2.69,"amount":443967.137064,"amplitude":0.123746,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.671347,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":3.07,"preHourTrading":{"tag":"盘前","latestPrice":3.07,"preClose":3.07,"latestTime":"08:46 EDT","volume":13,"amount":40.4100008,"timestamp":1790945185929,"change":0,"changeRate":0,"amplitude":0.016287},"postHourTrading":{"tag":"盘后","latestPrice":2.7399,"preClose":2.73,"latestTime":"19:30 EDT","volume":812,"amount":2210.1048,"timestamp":1790983852108,"change":0.0099,"changeRate":0.003626,"amplitude":0.012491},"volumeRatio":0.84612},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BSEM\",,,,,undefined,":{"symbol":"BSEM","floatShares":14044269,"roa":"-18.07%","roe":"-74.74%","lyrEps":-0.393388,"volumeRatio":0.84612,"shares":17935843,"dividePrice":0,"high":3.0699,"amplitude":0.123746,"preClose":3.07,"low":2.69,"week52Low":2.251,"pbRate":"1.77","psRate":"1.42","week52High":8.4,"institutionHeld":0,"latestPrice":2.73,"eps":-1.671347,"divideRate":0,"volume":158103,"delay":0,"ttmEps":-1.671347,"open":3.03,"prevYearClose":3.81,"prevWeekClose":4.14,"prevMonthClose":3.09,"prevQuarterClose":3.09,"fiveDayClose":4.14,"twentyDayClose":3.61,"sixtyDayClose":3.216},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BSEM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"BSEM","fiscalQuarterEnding":"2026/06","expectedEps":-0.5,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.52},{"date":"2026-05-14","symbol":"BSEM","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1778788800000,"name":null,"time":"Post-Mkt","dateTimestamp":1778731200000,"actualEps":null},{"date":"2026-03-24","symbol":"BSEM","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774339200000,"name":null,"time":"","dateTimestamp":1774324800000,"actualEps":null},{"date":"2025-11-13","symbol":"BSEM","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763024400000,"name":null,"time":"","dateTimestamp":1763010000000,"actualEps":null},{"date":"2025-08-14","symbol":"BSEM","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755158400000,"name":null,"time":"","dateTimestamp":1755144000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BSEM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BSEM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1778126400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BSEM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BSEM","date":"2026-10-01","current":-1.633413,"percent":0.973684,"low":-3.757423,"twenty":-2.731929,"median":-2.44801,"eighty":-2.23097,"high":-1.892791,"avg":-2.528545,"sd":0.424124,"marketCap":55154865},"quantilePoints":[{"date":"2026-08-06","current":-3.060802,"twenty":-3.060802,"median":-3.060802,"eighty":-3.060802,"marketCap":59100221},{"date":"2026-08-14","current":-1.982708,"twenty":-3.488616,"median":-3.39222,"eighty":-3.060802,"marketCap":54952215},{"date":"2026-08-21","current":-2.321824,"twenty":-3.470255,"median":-2.321824,"eighty":-1.987431,"marketCap":65686053},{"date":"2026-08-28","current":-2.429082,"twenty":-3.314185,"median":-2.362834,"eighty":-2.067302,"marketCap":68720463},{"date":"2026-09-04","current":-2.277659,"twenty":-3.060802,"median":-2.309205,"eighty":-2.110462,"marketCap":64436590},{"date":"2026-09-11","current":-2.634135,"twenty":-2.737134,"median":-2.321824,"eighty":-2.188697,"marketCap":74521541},{"date":"2026-09-18","current":-2.750857,"twenty":-2.725619,"median":-2.416463,"eighty":-2.223398,"marketCap":77823693},{"date":"2026-09-25","current":-2.44801,"twenty":-2.755904,"median":-2.44801,"eighty":-2.232232,"marketCap":69255947},{"date":"2026-10-01","current":-1.949575,"twenty":-2.731929,"median":-2.44801,"eighty":-2.23097,"marketCap":55154865}],"updateTime":1790983775329},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BSEM\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2642464941","title":"BRIEF-Biostem Technologies Announces Appointment Of Three New Members To Its Board Of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2642464941","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642464941?lang=en_us&edition=fundamental","pubTime":"2026-06-09 19:02","pubTimestamp":1781002923,"startTime":"0","endTime":"0","summary":"BRIEF-Biostem Technologies Announces Appointment Of Three New Members To Its Board Of DirectorsJune 9 (Reuters) - Biostem Technologies Inc BSEM.PK:BIOSTEM TECHNOLOGIES ANNOUNCES APPOINTMENT OF THREE N","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nTUA1DXPTH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSEM","BK4007","BK4139","MTVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642464147","title":"Press Release: BioStem Technologies Announces Appointment of Three New Members to its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2642464147","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642464147?lang=en_us&edition=fundamental","pubTime":"2026-06-09 19:02","pubTimestamp":1781002920,"startTime":"0","endTime":"0","summary":"POMPANO BEACH, Fla., June 09, 2026  -- BioStem Technologies Inc. , a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced the appointment of Mark Glickman, Steven D. Sonenreich, and Rayna Lesser Hannaway to its Board of Directors, effective as of June 5, 2026. In connection with their appointment to the Board of Directors, Mr. Sonenreich has been appointed as a member of the Audit Committee and the Corporate Governance and Nominating Committee, Ms. Hannaway has been appointed as a member of the Audit Committee and the Corporate Governance and Nominating Committee and Mr. Glickman has been appointed as a member and as Chair of the Compensation Committee. Concurrently, the Company also announced that Thomas Dugan and Patrick Daly have resigned from the board, effective as of June 4, 2026. Following these changes, the Company's Board of Directors consists of seven members.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","BK4022","BK4588","BK4604","R","BSEM","BK4232","BK4585","BK4099","BK4555","03160","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642346463","title":"Biostem Technologies Announces Appointment of Three New Members to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2642346463","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642346463?lang=en_us&edition=fundamental","pubTime":"2026-06-09 19:00","pubTimestamp":1781002801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nTUA1DXPTH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MTVA","BSEM","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637315024","title":"Biostem Technologies Announces $2.5 Million Private Placement Financing With Its First Institutional Investor","url":"https://stock-news.laohu8.com/highlight/detail?id=2637315024","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637315024?lang=en_us&edition=fundamental","pubTime":"2026-05-22 19:00","pubTimestamp":1779447600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nTUA98XHSQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BSEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635031534","title":"BioStem Technologies price target lowered to $7 from $9 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2635031534","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635031534?lang=en_us&edition=fundamental","pubTime":"2026-05-16 01:08","pubTimestamp":1778864934,"startTime":"0","endTime":"0","summary":"H.C. Wainwright lowered the firm’s price target on BioStem Technologies (BSEM) to $7 from $9 and keeps a Buy rating on the shares. The firm said th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biostem-technologies-price-target-lowered-to-7-from-9-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biostem-technologies-price-target-lowered-to-7-from-9-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BSEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635729596","title":"Press Release: BioStem Technologies Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2635729596","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635729596?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:59","pubTimestamp":1778792340,"startTime":"0","endTime":"0","summary":"POMPANO BEACH, Fla., May 14, 2026  -- BioStem Technologies, Inc. , a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today reported financial results for the first quarter ended March 31, 2026.-- Generated net revenue of $6.1 million for the first quarter 2026. -- Progressed integration initiatives following the BioTissue assets. -- Expanded direct sales force to 35 representatives, up from 18 at the. -- Strengthened leadership team with appointment of Katherine Gorrell as. notes, with an aggregate principal amount of $3 million. Net revenue was $6.1 million, compared to $10.1 million in the fourth quarter of 2025 and $16.0 million in the first quarter of 2025. Revenue for the first quarter was primarily driven by Neox and Clarix product sales. Hospital revenue represented approximately 87% of total revenue, or $5.4 million, and physician office revenue contributed $0.8 million.Gross profit w","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4099","BK4604","BK4588","BK4555","BK4585","03160","BK4232","TM","BK4022","R","BSEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635772542","title":"BioStem Technologies Q1 revenue falls 62% yr/yr","url":"https://stock-news.laohu8.com/highlight/detail?id=2635772542","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635772542?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:25","pubTimestamp":1778790325,"startTime":"0","endTime":"0","summary":"BioStem Technologies Q1 revenue falls 62% yr/yrOverviewRegenerative medicine firm's Q1 revenue fell sharply yr/yr after BioTissue asset acquisitionCompany posted Q1 net loss versus net income a year e","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL1N41R1A6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BSEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635723381","title":"Biostem Technologies, Inc. Q1 EPS USD -0.52","url":"https://stock-news.laohu8.com/highlight/detail?id=2635723381","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635723381?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:05","pubTimestamp":1778789104,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nPLX33198C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BSEM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633193653","title":"Biostem Technologies initiated with a Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2633193653","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633193653?lang=en_us&edition=fundamental","pubTime":"2026-05-07 11:26","pubTimestamp":1778124401,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Swayampakula Ramakanth initiated coverage of Biostem Technologies (BSEM) with a Buy rating and $9 price target While the de...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biostem-technologies-initiated-with-a-buy-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biostem-technologies-initiated-with-a-buy-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BSEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631636324","title":"Press Release: BioStem Strengthens Leadership Team with Appointment of Katherine Gorrell as Chief Legal & Compliance Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2631636324","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631636324?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:08","pubTimestamp":1777547280,"startTime":"0","endTime":"0","summary":"POMPANO BEACH, Fla., April 30, 2026  -- BioStem Technologies , a leading regenerative medicine company focused on the development, manufacturing and commercialization of perinatal tissue allograft products, today announced the appointment of Katherine Gorrell as Chief Legal & Compliance Officer, effective April 27, 2026.Ms. Gorrell has an extensive career advising hospital systems and health technology companies, with deep experience in health law, regulatory, transactional, compliance, governance, and risk management, as well as other business-oriented legal functions that facilitate strategic expansion and ensure operational excellence. In her role, she will oversee BioStem's legal and compliance functions and play a central role in enterprise governance, including the integration and oversight of Medical Affairs through BioStem's compliance framework.\"Katherine is a key addition to BioStem as we implement our next phase of growth,\" said Jason Matuszewski, Chairman and CEO of BioStem","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","TISI","BK4585","BK4604","TM","BK4232","BK4022","BK4555","BK4120","BSEM","BK4588","BK4007","03160","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631635813","title":"Biostem Strengthens Leadership Team With Appointment of Katherine Gorrell as Chief Legal & Compliance Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2631635813","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631635813?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:00","pubTimestamp":1777546802,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nTUA72V02Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BSEM"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":31,"code":"91000000","status":"200"}]}}